ArticleOrphanet journal of rare diseases2025

Postmarketing adverse events associated with onasemnogene abeparvovec: a real-world pharmacovigilance study.

Tianyu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.